These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36006548)
1. The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease. Zeng H; Tang C; Lin B; Yu M; Wang X; Wang J; Chen S; Yu C Hepatol Int; 2022 Oct; 16(5):1064-1074. PubMed ID: 36006548 [TBL] [Abstract][Full Text] [Related]
2. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney. Auberson M; Stadelmann S; Stoudmann C; Seuwen K; Koesters R; Thorens B; Bonny O Pflugers Arch; 2018 Dec; 470(12):1739-1751. PubMed ID: 30105595 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model Li L; Li Y; Luo J; Jiang Y; Zhao Z; Chen Y; Huang Q; Zhang L; Wu T; Pang J Food Funct; 2021 Sep; 12(18):8274-8287. PubMed ID: 34180933 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of SLC2A9/GLUT9 rs11722228 polymorphisms in gout. Das Gupta E; Sakthiswary R; Lee SL; Wong SF; Hussein H; Gun SC Int J Rheum Dis; 2018 Mar; 21(3):705-709. PubMed ID: 27456670 [TBL] [Abstract][Full Text] [Related]
5. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Dinour D; Gray NK; Ganon L; Knox AJ; Shalev H; Sela BA; Campbell S; Sawyer L; Shu X; Valsamidou E; Landau D; Wright AF; Holtzman EJ Nephrol Dial Transplant; 2012 Mar; 27(3):1035-41. PubMed ID: 21810765 [TBL] [Abstract][Full Text] [Related]
6. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease. Torres RJ; Puig JG Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice. Tang C; Cen L; Zeng H; Zhang X; Liu P; Chen Y; Song X; Lin B; Zhang X; Yu C; Xu C Cell Mol Gastroenterol Hepatol; 2024; 17(2):251-265. PubMed ID: 37879407 [TBL] [Abstract][Full Text] [Related]
8. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. Stark K; Reinhard W; Neureuther K; Wiedmann S; Sedlacek K; Baessler A; Fischer M; Weber S; Kaess B; Erdmann J; Schunkert H; Hengstenberg C PLoS One; 2008 Apr; 3(4):e1948. PubMed ID: 18398472 [TBL] [Abstract][Full Text] [Related]
9. The rs1014290 polymorphism of the SLC2A9 gene is associated with type 2 diabetes mellitus in Han Chinese. Liu WC; Hung CC; Chen SC; Lin MY; Chen LI; Hwang DY; Chang JM; Tsai JC; Chen HC; Hwang SJ Exp Diabetes Res; 2011; 2011():527520. PubMed ID: 21584282 [TBL] [Abstract][Full Text] [Related]
10. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645 [TBL] [Abstract][Full Text] [Related]
11. The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway. Nie Q; Liu M; Zhang Z; Zhang X; Wang C; Song G Mol Biol Rep; 2021 Dec; 48(12):8023-8032. PubMed ID: 34716863 [TBL] [Abstract][Full Text] [Related]
12. Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake. Liu S; Yuan Y; Zhou Y; Zhao M; Chen Y; Cheng J; Lu Y; Liu J J Cell Mol Med; 2017 Oct; 21(10):2553-2562. PubMed ID: 28402018 [TBL] [Abstract][Full Text] [Related]
13. SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration. Ware EB; Riehle E; Smith JA; Zhao W; Turner ST; Kardia SL; Lieske JC PLoS One; 2015; 10(7):e0128593. PubMed ID: 26167684 [TBL] [Abstract][Full Text] [Related]
14. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255 [TBL] [Abstract][Full Text] [Related]
15. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Preitner F; Bonny O; Laverrière A; Rotman S; Firsov D; Da Costa A; Metref S; Thorens B Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15501-6. PubMed ID: 19706426 [TBL] [Abstract][Full Text] [Related]
17. Facilitative glucose transporter 9, a unique hexose and urate transporter. Doblado M; Moley KH Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E831-5. PubMed ID: 19797240 [TBL] [Abstract][Full Text] [Related]
18. Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes. Zhang B; Duan M; Long B; Zhang B; Wang D; Zhang Y; Chen J; Huang X; Jiao Y; Zhu L; Zeng X Mol Med Rep; 2019 Aug; 20(2):1645-1654. PubMed ID: 31257523 [TBL] [Abstract][Full Text] [Related]
19. Association of an intronic SNP of SLC2A9 gene with serum uric acid levels in the Chinese male Han population by high-resolution melting method. Guan M; Zhou D; Ma W; Chen Y; Zhang J; Zou H Clin Rheumatol; 2011 Jan; 30(1):29-35. PubMed ID: 20972595 [TBL] [Abstract][Full Text] [Related]
20. Association of a polymorphism in a gene encoding a urate transporter with CKD progression. Testa A; Mallamaci F; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Leonardis D; Zoccali C Clin J Am Soc Nephrol; 2014 Jun; 9(6):1059-65. PubMed ID: 24742479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]